Hikma Pharmaceuticals Share News (HIK)

Dividends Calendar - Week Ahead

Hikma Pharmaceuticals under pressure as founder dies

Shares in Hikma Pharmaceuticals were under pressure on Monday, down 2% after the company said its founder and major shareholder, Samih Darwazah, passed away last Friday at the age of 85. Hikma floated on the London Stock Exchange in 20105 and entered the FTSE 100 index in March 2015, replacing Tullo

BUZZ-Hikma: founder's death puts pressure on stock

(Updates to include official statement) ** Jordanian-based pharma co Hikma Pharmaceuticals top UK blue-chip faller after company says founder Samih Darwazah died on Friday, aged 85 ** Darhold Ltd, the holding co through which the Darwazah family & other founding shareholders hold the

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

Dividends Calendar - Week Ahead

London close: Stocks stage late rally after positive US labour data

After a negative start, UK stocks rallied into the close as improving labour-market data from the States lifted sentiment. After a choppy week, owing mainly to volatility on the government bond market, Wall Street indices opened higher following a Labor Department report which showed that US jobless

LONDON MARKET CLOSE: Stocks Track US Equities Higher

Dividends Calendar - Week Ahead

FTSE 100 movers: ITV hit by strike and stiff BBC competition, miners lower

UK stocks rebounded from early losses, but remained restrained by concerns of Greek instability. Sector wise, miners and technology services provided the biggest drag, while insurers and utilities gave a welcome boost. At 1:45 BST, the FTSE 100 was trading 12 points higher at 6,962. ITV declined a

London midday: Stocks erase losses as markets continue erratic moves

UK stocks erased losses by Thursday lunchtime on a quiet session for economic data, though concerns about Greece were limiting upside. Reports that Greek finance minister Yanis Varoufakis has called for the European Central Bank to delay Athens' debt repayments shook sentiment among investors. The

LONDON MIDDAY BRIEFING: ITV Hit By Strike, Weaker Outlook

TOP NEWS: ITV, Hikma And Merlin Provide Positive Outlooks For 2015

LONDON MARKET COMMENT: Stocks Mixed As 3i Group Leads Large Caps

Hikma confident for full year as injectables and generics start well

Hikma Pharmaceuticals said it had enjoyed a good start to the year and said revenues at its Injectables division would remain at a similar level to last year's but with a slight decline in operating profit margins. Ahead of its annual shareholder meeting on Thursday, the FTSE 100 group reiterated it